Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0376358 (prostate cancer)
 59,338 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Cryosurgery has a wide range of uses for the destruction of tumours. Acceptability among dermatologists for the treatment of skin cancer appears high. In the treatment of oral cancer, cryosurgery is not yet widely accepted, but it should be more commonly used for early cancer and in the management of selected problems in therapy. It has established a reasonably firm place in the treatment of prostatic cancer, perhaps because of continued interest in the immunologic benefits, while its use in gynecologic organs is limited to carcinoma in situ or to selected patients with advanced cancer. In all these areas, it has been used with surprisingly good results in selected patients who were high risks under conventional methods of therapy. The trial of cryosurgery in the treatment of bone tumors should prove its efficacy. Today's interest in cryosurgery is consistent with the current trend to conservatism in cancer surgery.
 ...
PMID:Cryosurgery for cancer. 7 80

In Canada, it is estimated that in 1992 115,000 new cases of cancer will be diagnosed. This total excludes 47,200 estimated new cases of non-melanoma skin cancer. The number of new cases is increasing by about 3,000 per year due partly to the aging population, improved registration, earlier detection of cancer and real increases in the incidence of some types of cancer. It is estimated that there will be 58,300 cancer deaths in 1992. By 1992, prostate cancer will have overtaken lung cancer as the leading cancer among men in the four western provinces while lung cancer is expected to exceed breast cancer as the leading cause of cancer deaths among women in some provinces, notably British Columbia. In British Columbia, the relative survival rates for most cancers improved between the periods 1970 to 1974 and 1980 to 1984. However, stomach, lung and pancreatic cancers, which have low survival rates, showed little improvement. This article is based on 1992 estimates of cancer incidence and mortality, cancer trends in Canada and relative cancer survival rates in British Columbia, found in Canadian Cancer Statistics 1992. This publication was prepared at Statistics Canada through a collaborative effort involving the Canadian Cancer Society, Health and Welfare Canada and the provincial/territorial cancer registries.
 ...
PMID:1992 Canadian Cancer Statistics. 142 Oct 19

The Zimbabwe National Cancer Registry began operation in 1986. Between 1986-1989, a total of 8 276 cases were identified. Among men of African descent, oesophageal (11.2 pc) and liver cancer (11.0 pc) were most common. Cervical cancer was by far the most common among women of African descent (34.5 pc). Among both males and females of non-African descent, skin cancers (other than melanoma) accounted for one-third of cancers followed by prostate cancer (7.7 pc) in males and breast cancer (18.5 pc) in females. These findings are comparable to earlier reports of the epidemiology of cancer in Zimbabwe.
 ...
PMID:Zimbabwe National Cancer Registry: summary data 1986-1989. National Cancer Registry Advisory Committee. 151 26

Prostate cancer is the most frequently occurring non-skin cancer in men in the U.S.A. and other Western countries, but its etiology is poorly understood. Human prostate carcinogenesis has been viewed as a multi-step process involving progression from low histologic grade, small latent carcinoma, to large, higher grade, metastasizing carcinoma. However, recent data suggest that a variety of pathogenetic pathways exist. The precise role of hormones in the genesis of human prostate cancer remains largely undefined. It is difficult to investigate stages in the development of human prostate cancer, but some animal models provide opportunities in this regard. Short-term treatment of rats with chemical carcinogens will produce a low incidence (5-15%) of prostate cancer, provided that prostatic cell proliferation is enhanced during carcinogen exposure. A high carcinoma incidence can only be produced by chronic treatment with testosterone following administration of carcinogens such as N-methyl-N-nitrosourea (MNU). Testosterone markedly enhances prostate carcinogenesis even at doses that do not measurably increase circulating testosterone. Thus, testosterone is a strong tumor promoter for the rat prostate. All such MNU-initiated, testosterone-promoted tumors are adenocarcinomas mostly originating from the dorsolateral and anterior, but not ventral, prostate lobes. A high frequency (70%) of activation of the K-ras gene by a G35 to A mutation occurs in these carcinomas. A variable frequency of activation of H-ras and K-ras genes occurs in human prostate carcinomas. Another rat model, representing a different pathogenetic pathway, involves chronic administration of estradiol-17 beta in combination with low-dose testosterone. The resulting carcinomas are low-grade and originate exclusively from periurethral ducts of the dorsolateral and anterior prostate. We recently found a major adduct by 32P postlabeling analysis in the tissue region that includes these ducts, but not in, e.g., the ventral prostate, of rats treated for 16-24 weeks. While it is unknown whether testosterone is a tumor promoter in this system, the presence of a DNA adduct suggests that estradiol-17 beta acts as a tumor-initiating agent in this system.
 ...
PMID:Multistage prostate carcinogenesis: the role of hormones. 184 35

The incidence, predisposing factors, localization, evolution and outcome of neoplasms following kidney transplantation were studied in two groups of patients--120 and 146 patients for an observation period from 1 to 16 years. In patients with adequate renal function who received immunosuppressive treatment for more than one year (accordingly 78 and 88 patients) neoplasms developed in 4 and 10 patients with mean duration of immunosuppressive treatment 4.9 and 6.1 years respectively. The neoplasms were: 3 skin cancers, 2 lung cancers, 2 Kaposi sarcomas, 1 lymphosarcoma, 1 breast cancer, 1 prostate cancer, 1 renal cancer, 1 rectal cancer and 2 polyps of the colon. The case fatality rate was 3.6 per cent. The importance of precision of the immunosuppressive treatment for reducing the incidence of these complications is pointed out.
 ...
PMID:[Neoplasms following kidney transplantation]. 194 1

Experimental evidence indicates a relationship between cholesterol alpha-epoxide and skin cancer, and exposure of skin fibroblasts to ultraviolet radiation enduces formation of significant levels of this oxide. Colon cancer is also etiologically linked to cholesterol oxidation products. Higher than normal levels of cholestanetriol have been found in patients with colon cancer and also in those with precancerous disorders such as adenomatous polyps and ulcerative colitis. Higher than normal levels of cholesterol alpha-epoxide have been found in breast fluid aspirates of women with benign breast disease, with or without atypical hyperplasia of the epithelium, and this may be a factor in the increased incidence of breast cancer associated with hyperplasia. Similarly, the observed increased levels of cholesterol alpha and beta-epoxides in prostatic fluid of men with benign prostatic hypertrophy may be associated with subsequent development of prostate cancer. Cholesterol alpha-epoxide has been found to be mutagenic to fibroblasts in culture and to induce morphological transformation in hamster embryo cells and in mouse C3H cells. 25-Hydroxycholesterol and 20 alpha-hydroxycholesterol are potent suppressors of generation and proliferation of tumor-specific cytotoxic T lymphocytes. Although investigations into the role of cholesterol oxidation products in cancer are still in the early stages, evidence to date indicates a potentially significant role in the induction of some types of cancer.
 ...
PMID:Cholesterol oxides and carcinogenesis. 206 46

Case-control studies have been carried out in Alberta in the last seven years to investigate possible risk factors for cancer of the prostate, skin and ovary. For each study, controls were randomly selected from an age- and sex-matched population. The information obtained from each control that agreed to participate in each study (n = 1236) included name, sex, date of birth, address and date of participation as well as the specific questions for each study. A review of these controls was carried out in 1988 by checking the number of deaths through death certificate listings from Vital Statistics (n = 142) and cancer incidence through the population-based Alberta Cancer Registry (n = 134). Of the 619 controls interviewed for the prostate cancer case control study in 1982 and 1983, 25 have been diagnosed with cancer of the prostate. From the non-melanoma skin cancer study, 15 cases from the 409 controls interviewed in 1983-1984 have been diagnosed with non-melanoma skin cancer. As for the 208 controls for ovarian cancer interviewed in 1985-1986 no new cases have been diagnosed. This possible ascertainment bias should be taken under consideration when case-control study analyses are carried out.
 ...
PMID:Follow-up of controls participating in case-control studies for cancer risk factors. 195 70

The usual measures of the magnitude of the cancer problem are annual incidence and mortality data. We present another measure of the magnitude of the cancer problem. We computed the probabilities at birth and at various ages of developing or dying of the disease within 10 years, 20 years, or total lifetime and show the trends that have occurred in these data since 1975. These probabilities were computed for males and females and among whites and blacks for 1975 and 1980, and projected to 1985. The data indicate a continuing, albeit modest, increase in the probabilities of eventually developing cancer in each of the four sex-race groups, both excluding and including carcinoma in situ. White males now show the highest probability at birth of eventually developing cancer, and black females, the lowest, with the figures for the other two groups being intermediate. Larger increases were seen for males between 1980 and 1985 (more than three percent) than for females (two percent or less). A child born in the US in 1985 has more than one in three chances of eventually developing invasive cancer (exclusive of epidermoid skin cancer). By site, for males the largest probabilities and the largest increases in the probabilities are for eventually developing lung and prostate cancer. For women, the largest eventual probabilities are for breast cancer, almost one in 10 for white females and one in 14 for black females. The largest increases are seen for lung cancer and cancer of the colon-rectum. The probability of eventually dying of cancer is increasing among the four sex-race groups and is now greater for males of both races than for their female counterparts. For males born in 1985, the chances of eventual death from cancer are almost one in four, and for females, almost one in five. With the long-term, downward trends in terms of other causes of death--most specifically, decreases in mortality from cardiovascular diseases--the effect on the population at large is greater longevity. This situation, in turn, leaves more people longer time to be exposed to cancer risks. Thus, while the probabilities of developing or dying of cancer are seen to increase, the increases should be viewed in light of the increasing numbers of people available for such an occurrence.(ABSTRACT TRUNCATED AT 400 WORDS)
 ...
PMID:Probabilities of eventually developing or dying of cancer--United States, 1985. 391 41

Death certificate information identified 9,245 white and 3,508 nonwhite men who died in North Carolina during 1976-1978 and who had been farmers. The distribution of deaths from various causes among these men was compared to that of other male decedents in the state. For both white and nonwhite farmers, proportional mortality ratios (PMRs) were elevated for tuberculosis (whites, 1.6; nonwhites, 1.7), diseases of the skin and subcutaneous tissue (whites, 2.5; nonwhites, 1.5), and external causes (whites, 1.2; nonwhites, 1.1) and were decreased for cancers of the esophagus (whites and nonwhites, 0.5) and large intestine and rectum (whites and nonwhites, 0.7). White farmers had an increased relative frequency of melanoma (PMR = 1.2) and other skin cancer (PMR = 1.8), while nonwhite farmers had an increased relative frequency of melanoma (PMR = 6.3), brain cancer (PMR = 2.3), and leukemia (PMR = 1.9). In addition, among decedents under 65 years of age, both white and nonwhite farmers had an elevated proportional mortality ratio for prostate cancer (whites, 1.6; nonwhites, 1.3). Many of these results are consistent with observations from other studies. Some of these findings, particularly those for nonwhites, warrant further evaluation, including detailed investigation of possibly related farming practices.
 ...
PMID:Mortality among white and nonwhite farmers in North Carolina, 1976-1978. 401 29

Age-adjusted incidence rates for males and females for 36 cancer sites across 29 census sub-divisions of the province of Alberta were correlated with one another. It was hypothesized that cancers which vary together across geographical areas may have common aetiological factors. The correlations were measured by the Pearson product moment coefficient, r, and illustrated by scatter graphs and regression lines. For males moderate correlations were found between prostate and skin cancer and between prostate cancer and non-Hodgkin's lymphoma. Also moderately correlated were male stomach and small intestine cancers and cancers of the bladder and the buccal cavity and pharynx. Specific site correlations for cancers in females were generally higher than for cancers in males. The highest correlations were found between cancer of cervix (invasive) and cancer of trachea, bronchus and lung, between multiple myeloma and cancer of brain and nervous system, between acute lymphatic leukemia and cancer of the bone and connective tissue, and between melanoma and cancer of bone and connective tissue. Although all these correlations are moderate they nevertheless indicate substantial relationships. Possible common aetiologic factors for correlating pairs of cancers are discussed.
 ...
PMID:Correlation of incidence rates for selected cancers in 29 census sub-divisions of Alberta, Canada, 1961-1981. 633 9


1 2 3 4 5 6 7 8 9 10 Next >>